Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Short vs Standard Treatment in AECOPD
NCT03698682Phase 2Completed
- Sponsor
- Université de Monastir
- Start
- Jan 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levofloxacin in chronic obstructive pulmonary disease (COPD), sponsored by Université de Monastir. Started Jan 2018; status: completed.
02
Drugs
levofloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03698682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03698682.